|Articles|November 13, 2020
Biological Decontamination of a Vaccine Production Facility
Author(s)Bioquell
An industrial biotechnology company in Denmark required more rigorous control measures to ensure a high level of bio-decontamination in its facility. An automated hydrogen peroxide vapor service from Bioquell was selected.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Roche Drives Industry Shift With Three-Year Lymphoma Survival Data
2
How Mitigation and Maintenance Protect Against Future Risk
3
Navigating the Next Wave of Biopharma Manufacturing Innovation
4
FAQ: Milestones You May Have Missed in the 2025 Biopharma Pipeline
5
